Small biotech teams face high failure rates and long discovery timelines due to limited data and costly iteration. RxPlora addresses this with proprietary, signal-driven AI models that learns from small experimental datasets to predict potent, target-specific leads reducing risk while cutting discovery time and cost by up to 90%.
Learn more about our three platforms:
RxPlora ™ Base, RxPlora Extract© and RxPlora Predict©
Our Technology Platform
Machine Learning Algorithms
Our platform utilizes state-of-the-art machine learning algorithms to analyze massive datasets, identifying patterns and correlations that may go unnoticed through traditional methods.
Predictive Analytics
We employ predictive analytics to forecast potential drug candidates, saving time and resources by focusing on the most promising avenues.
Data Integration
Seamlessly integrate and analyze diverse datasets, including genomics, proteomics, and chemical data, providing a comprehensive understanding of the biological landscape.
Automated Screening
Speed up the screening process with our automated tools, allowing for rapid identification of potential drug candidates and accelerating the drug discovery timeline.
Key Features of RxPlora Base product
Customizable Workflows: Tailor our platform to fit your specific research needs. Our customizable workflows ensure that you get the insights that matter most to your project.
Real-time Collaboration: Foster collaboration among research teams by providing a centralized platform for sharing findings, insights, and progress.
User-Friendly Interface: Our intuitive interface makes it easy for scientists and researchers to interact with the platform, even if they have limited experience with AI and machine learning.
Continuous Learning: Our platform evolves with your research. As new data becomes available, our algorithms continuously learn and adapt, ensuring that you always have access to the latest insights.